LPTX: Leap Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 111.89
Enterprise Value ($M) 49.07
Book Value ($M) 48.95
Book Value / Share 1.28
Price / Book 2.29
NCAV ($M) 47.72
NCAV / Share 1.25
Price / NCAV 2.34

Profitability (mra)
Return on Invested Capital (ROIC) -1.31
Return on Assets (ROA) -0.78
Return on Equity (ROE) -0.90

Liquidity (mrq)
Quick Ratio 3.97
Current Ratio 3.97

Balance Sheet (mrq) ($M)
Current Assets 63.81
Assets 65.05
Liabilities 16.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G Balyasny Asset Management Llc 8.06
10-31 13D/A Beigene, Ltd. 3.17 -90.00
04-25 13G Samsara BioCapital, L.P. 6.40
04-19 13G Gilead Sciences Inc 13.90
02-14 13G/A Perceptive Advisors Llc 4.00 -84.12

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-29 68,705 209,412 32.81
2024-11-27 103,226 373,123 27.67
2024-11-26 24,472 341,606 7.16

(click for more detail)

Similar Companies
LIPO – Lipella Pharmaceuticals Inc. LIXT – Lixte Biotechnology Holdings, Inc.
LPCN – Lipocine Inc. LQDA – Liquidia Corporation
LSTA – Lisata Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io